Here are five things to know:
1. Lijun Rong, PhD, University of Illinois at Chicago professor in microbiology and immunology, and his team found that the way Ebola and Marburg enter host cells is through a cell surface receptor.
2. The cell surface receptor is a protein named GPCR, which is part of many biological processes.
3. Because there are thousands of GPCRs in humans, many drugs are already in circulation to combat diseases associated with them.
4. The researchers discovered that 20 GPCR antagonists could hinder Ebola and Marburg viruses from entering host cells.
5. Dr. Rong concluded that there are many existing drugs that may be key in stopping Ebola and Marburg.
More articles on quality & infection control:
Xenex Germ-Zapping Robot cleans up Miami’s Nicklaus Children’s Hospital: 6 points
California could mandate quality, cost transparency for outpatient services; CASA onboard
CMS extends quality reporting deadline to Sept. 1: 5 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
